280 related articles for article (PubMed ID: 32565797)
1. Differential MicroRNA-Signatures in Thyroid Cancer Subtypes.
Santiago K; Chen Wongworawat Y; Khan S
J Oncol; 2020; 2020():2052396. PubMed ID: 32565797
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin.
Braun J; Hüttelmaier S
Thyroid Res; 2011 Aug; 4 Suppl 1(Suppl 1):S1. PubMed ID: 21835047
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Acquaviva G; Visani M; Repaci A; Rhoden KJ; de Biase D; Pession A; Giovanni T
Histopathology; 2018 Jan; 72(1):6-31. PubMed ID: 29239040
[TBL] [Abstract][Full Text] [Related]
5. The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.
Pishkari S; Paryan M; Hashemi M; Baldini E; Mohammadi-Yeganeh S
J Endocrinol Invest; 2018 Mar; 41(3):269-283. PubMed ID: 28762013
[TBL] [Abstract][Full Text] [Related]
6. Molecular and genetic markers of follicular-cell thyroid cancer: etiology and diagnostic and therapeutic opportunities.
Goyal N; Setabutr D; Abdulghani J; Goldenberg D
Adv Exp Med Biol; 2013; 779():309-26. PubMed ID: 23288646
[TBL] [Abstract][Full Text] [Related]
7. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract][Full Text] [Related]
8. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
9. Molecular Genetics of Follicular-Derived Thyroid Cancer.
Macerola E; Poma AM; Vignali P; Basolo A; Ugolini C; Torregrossa L; Santini F; Basolo F
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33799953
[TBL] [Abstract][Full Text] [Related]
10. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
11. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
12. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
13. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
[TBL] [Abstract][Full Text] [Related]
14. Molecular events in follicular thyroid tumors.
Kroll TG
Cancer Treat Res; 2004; 122():85-105. PubMed ID: 16209039
[TBL] [Abstract][Full Text] [Related]
15. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
Erler P; Keutgen XM; Crowley MJ; Zetoune T; Kundel A; Kleiman D; Beninato T; Scognamiglio T; Elemento O; Zarnegar R; Fahey TJ
Surgery; 2014 Dec; 156(6):1342-50; discussion 1350. PubMed ID: 25456905
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
Rodríguez-Rodero S; Fernández AF; Fernández-Morera JL; Castro-Santos P; Bayon GF; Ferrero C; Urdinguio RG; Gonzalez-Marquez R; Suarez C; Fernández-Vega I; Fresno Forcelledo MF; Martínez-Camblor P; Mancikova V; Castelblanco E; Perez M; Marrón PI; Mendiola M; Hardisson D; Santisteban P; Riesco-Eizaguirre G; Matías-Guiu X; Carnero A; Robledo M; Delgado-Álvarez E; Menéndez-Torre E; Fraga MF
J Clin Endocrinol Metab; 2013 Jul; 98(7):2811-21. PubMed ID: 23666970
[TBL] [Abstract][Full Text] [Related]
17. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
Schröder S
Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
[TBL] [Abstract][Full Text] [Related]
18. Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.
Schwertheim S; Wein F; Lennartz K; Worm K; Schmid KW; Sheu-Grabellus SY
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1143-1154. PubMed ID: 28265769
[TBL] [Abstract][Full Text] [Related]
19. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
[TBL] [Abstract][Full Text] [Related]
20. Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer.
Salajegheh A; Vosgha H; Md Rahman A; Amin M; Smith RA; Lam AK
J Mol Endocrinol; 2015 Dec; 55(3):183-96. PubMed ID: 26342107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
